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Dendritic cells are considered as the main coordinators of both mucosal and systemic 
immune responses, thus playing a determining role in shaping the outcome of effector 
cell responses. However, it is still uncovered how primary human monocyte-derived 
DC (moDC) populations drive the polarization of helper T (Th) cells in the presence of 
commensal bacteria harboring unique immunomodulatory properties. Furthermore, 
the individual members of the gut microbiota have the potential to modulate the out-
come of immune responses and shape the immunogenicity of differentiating moDCs 
via the activation of retinoic acid receptor alpha (RARα). Here, we report that moDCs 
are able to mediate robust Th1 and Th17 responses upon stimulation by Escherichia 
coli Schaedler or Morganella morganii, while the probiotic Bacillus subtilis strain limits 
this effect. Moreover, physiological concentrations of all-trans retinoic acid (ATRA) are 
able to re-program the differentiation of moDCs resulting in altered gene expression 
profiles of the master transcription factors RARα and interferon regulatory factor 4, and 
concomitantly regulate the cell surface expression levels of CD1 proteins and also the 
mucosa-associated CD103 integrin to different directions. It was also demonstrated that 
the ATRA-conditioned moDCs exhibited enhanced pro-inflammatory cytokine secretion 
while reduced their co-stimulatory and antigen-presenting capacity thus reducing Th1 
and presenting undetectable Th17 type responses against the tested microbiota strains. 
Importantly, these regulatory circuits could be prevented by the selective inhibition of 
RARα functionality. These results altogether demonstrate that selected commensal bac-
terial strains are able to drive strong effector immune responses by moDCs, while in the 
presence of ATRA, they support the development of both tolerogenic and inflammatory 
moDC in a RARα-dependent manner.
Keywords: monocyte-derived dentritic cell, gut microbiota, all-trans retinoic acid, retinoic acid receptor alpha, 
interferon regulatory factor 4, T cell, cD1a, cD1d
inTrODUcTiOn
The development and the metabolic activity of the human immune system critically depend on the 
amount and the diversity of the human microbiota acquired from the actual tissue microenvironment 
(1, 2). Upon birth, the human gastrointestinal tract becomes colonized by commensal microbes co-
evolved with humans in a symbiotic or at least mutualistic manner together with the immune system 
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(3, 4). The local dendritic cell (DC) network involves a highly 
heterogeneous population of cells of myeloid and bone marrow 
origin (5), and in the course of this balancing regulation, moDCs 
also act as potent organizers of adaptive immunity leading to 
the maintenance of peripheral tolerance against the gut resident 
microbes. However, our knowledge about the interplay of molecular 
interactions during diet involving vitamin A supplementation, and 
the presence of gut microbiota species in the course of an ongoing 
human immune system is still limited in both health and diseases.
The uncontrolled disruption of the gut microbiota can be 
provoked by dysbiosis due to excessive hygiene conditions and/or 
the presence of antibiotics. This microbial perturbation may play 
role in the pathogenesis of chronic inflammatory and autoim-
mune diseases such as inflammatory bowel diseases (IBD), celiac 
disease, allergy, and metabolic and neurobehavioral diseases. For 
example, in Crohn’s disease, the ratio of Proteobacteria could be 
increased (6), while the diversity and the fraction of Firmicutes 
in the gut microbiota are decreased (7). Colonization with com-
mensal Escherichia coli 083 and Lactobacillus rhamnosus strains 
in early life is able to decrease the incidence of allergies and atopic 
dermatitis, respectively (8, 9). The various effects of probiotic gut 
bacteria also may prevent infection by pathogens such as the 
probiotic E. coli Nissle 1917 strain, which is able to inhibit the 
growth of enteropathogenic E. coli, which also may serve as a safe 
strain in IBD treatment (10–12).
Here, we focus to the underlying mechanisms involved in the 
recognition and processing of different species of gut commensal 
and beneficial bacteria and to their ability to polarize helper T (Th) 
lymphocytes. Considering that the human commensal micro-
biota is personalized (13) and exhibits high heterogeneity, it also 
contributes to the development of protective immune responses 
against pathogens via modulating the type and the composition 
of gut resident effector T  cells (13–15). It is well established 
that pathogenic microbes or pathobionts, including fungal and 
bacterial species, are able to induce different types of immune 
responses (16, 17), which are modulated by external and internal 
signals. However, the means how non-pathogenic gut commensal 
species contribute to the coordination and fine tuning of immune 
responses by moDCs is not completely uncovered. In line with this, 
the primary goal of this study was to characterize a selected set of 
the normal gut microbiota including Escherichia coli var. mutabilis 
(E. coli Schaedler), Morganella morganii from Proteobacteria, and 
probiotic Bacillus subtilis 090 from Firmicutes, all with individual 
immunogenic and/or modulatory potential during moDC matu-
ration and T-lymphocyte polarization. As it has previously been 
described, E. coli Schaedler and M. morganii exert unique stimula-
tory effects on the developing immune system and are also able 
to induce oral tolerance in mice (18), while B. subtilis is widely 
used in veterinary practice based on the active constituents of 
probiotic Monosporyn™ developed at the Uzhhorod National 
University. Upon interaction with the mucosal immune system, 
tolerogenic immune responses are raised against commensal and 
beneficial microbes. However, it is still poorly understood how 
the special but highly complex and dynamic intestinal milieu 
impacts the differentiation program of moDCs and the outcome 
of moDC-mediated immunological processes initiated by normal 
microbiota members and probiotic bacteria such as B. subtilis 090.
The differentiation program of monocytes during moDC 
generation is initiated by granulocyte-macrophage colony-stimu-
lating factor (GM-CSF) and interleukin (IL)-4 and is regulated by 
the peroxisome proliferator-activated receptor gamma (PPARγ) 
(19). PPARγ is known to collaborate with retinoid receptors and 
acts as a master transcriptional regulator in human moDC dif-
ferentiation and function (19). In addition, a set of genes encod-
ing proteins related to metabolism, lipid antigen processing and 
presentation, invariant natural killer T (iNKT) cell activation, and 
RA synthesis are regulated by PPARγ and overlaps with those reg-
ulated by retinoic acid receptor alpha (RARα) (20–23), showing 
that RARα also serves as a master regulator of moDC functions. In 
humans, the vitamin A derivate all-trans retinoic acid (ATRA) is 
produced endogenously from retinol by DCs, macrophages, and 
epithelial and stromal cells (20, 24–27) and binds to RARα and 
retinoic X receptor alpha (RXRα) with different affinities (28) 
and enables to follow up the modulatory effects of the retinoid 
pathways in moDC-mediated immune responses. Besides target-
ing the highly conserved receptor RARα (29), ATRA also serves 
as a potential therapeutic drug in anticancer settings (30) and in 
combinations with other therapeutic agents such as GM-CSF (31) 
able to promote myelomonocytic differentiation.
We hypothesize that human monocytes migrating from 
the blood to the intestinal lamina propria have access to these 
special microenvironments, which are conditioned by growth 
factors and metabolites, including GM-CSF, exogenous and/or 
endogenous ATRA, and take part in the coordination of immune 
responses raised against the targeted gut commensal species. 
Intestinal mononuclear cells express mucosa-associated cell 
surface molecules such as CX3CR1 and/or CD103 (32, 33). The 
main sources of human intestinal CX3CR1+ DCs are circulating 
monocytes, which lose this marker within 24 h (34). In contrast 
to this event, the CX3CR1 chemokine receptor remains expressed 
on the cell surface of intestinal mononuclear phagocytes and 
acts directly as an inflammatory and migratory cell population 
with high phagocytic capacity (34–37), while mucosal CD103+ 
DCs have been described as a dominant migratory population 
involved in triggering regulatory T cell responses raised against 
commensal bacteria via producing RA (38).
Based on this concept, in vitro conditions were designed to 
analyze the canonical pathways leading to the ATRA-modulated 
expression of the contributing master transcription factors 
including retinoid receptors, PPARγ and interferon regulatory 
factor 4 (IRF4) playing role in moDC differentiation in line with 
the impact of different, individual commensal bacteria exerted 
on moDC-mediated inflammation and effector T-lymphocyte 
priming. In this context, we will follow up the phenotypic 
changes and the functional activities of moDC populations by 
monitoring their phagocytic potential, inflammatory nature, 
and immunogenicity. Taken the unique intestinal microenviron-
ment and the complex interplay of various exogenous effects, we 
sought to demonstrate how external and internal stimuli derived 
from the engulfed commensal E. coli Schaedler, M. morganii, and 
the probiotic B. subtilis bacteria may impact on the development 
of effector T-lymphocyte activation and polarization followed 
up by the production of interferon gamma (IFNγ) and IL-17 
cytokines.
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MaTerials anD MeThODs
Bacterial strains and reagents
The experiments were performed with the commensal bacteria as 
follows: E. coli var. mutabilis (Schaedler) (O83:K24:H31, member 
of the original Schaedler’s flora), M. morganii, and B. subtilis 090. 
M. morganii was kindly provided by Michael Potter, National 
Institutes of Health, strain E. coli Schaedler was obtained from 
Russel Schaedler, USA, and B. subtilis 090 was provided by Nadiya 
Boyko, National University of Uzhhorod, Ukraine. Both com-
mensal gut microbiota strains were received by the R&D Centre 
for Molecular Microbiology and mucosal immunology from 
Pennsylvania University in the framework of a research coop-
eration agreement. ATRA, the selective RARα antagonist BMS-
195614 (BMS614), the vehicle dimethyl-sulfoxide (DMSO), and 
the anti-hβ-actin mAb were from Sigma-Aldrich, Schnelldorf, 
Germany. The anti-hIRF4 antibody was from Cell Signaling 
Technology, Inc. (Trask Lane, Danvers, MA, USA).
human moDc cultures
Peripheral blood mononuclear cells (PBMCs) were separated by 
a standard density gradient centrifugation with Ficoll-Paque Plus 
(Amersham Biosciences, Uppsala, Sweden). Monocytes were 
purified from PBMCs by positive selection using immunomag-
netic cell separation and anti-CD14 microbeads, according to the 
manufacturer’s instruction (Miltenyi Biotec, Bergisch Gladbach, 
Germany). After separation on a VarioMACS magnet, 96–99% 
of the cells were shown to be CD14+ monocytes, as measured by 
flow cytometry. Isolated monocytes were cultured for 2 days in 
12-well tissue culture plates at a density of 5.0 × 105 cells/ml in 
Gibco’s serum-free AIM-V medium (Thermo Fischer Scientific, 
Waltham, MA, USA) supplemented with 80  ng/ml GM-CSF 
(Gentaur Molecular Products, Brussels, Belgium) and 100 ng/ml 
IL-4 (PeproTech EC, London, UK). The cells were differentiated 
in the presence or absence of 1 nM ATRA followed by a 75-min 
incubation period with or without 1 µM BMS614 specific RARα-
antagonist at 37°C atmosphere containing 5% CO2.
Bacterial growth for moDc activation
Selected gut commensal bacteria were grown in 2% lysogeny 
broth medium (Serva Electrophoresis GmbH, Heidelberg, Ger-
many) for overnight with shaking at 37°C. Bacterial suspensions 
were washed with 25 ml sterile phosphate-buffered saline (PBS) 
three times and OD600nm was measured by spectrophotometry 
and converted to cell/ml following OD600nm × 2.5 × 108 CFU/ml. 
Human moDC cultures were activated with the specific toll-like 
receptor ligand bacterial lipopolysaccharide (LPS) (250  ng/ml 
ultrapure LPS, InvivoGen, San Diego, CA, USA) and with live 
commensal bacteria at a non-toxic ratio of 1:0.4 and were co-
cultured for another 24 h.
Phagocytosis assay
Live bacterial cells were centrifuged at 1,000 × g for 5 min and 
washed three times in 25 ml PBS. Suspensions of bacterial cells 
were heat inactivated by heating at 65°C for 45  min and were 
re-suspended in 0.25 M carbonate–bicarbonate buffer (pH 9.0). 
The heat-killed bacterial cell suspensions (900 µl) were stained 
with 100 µl fluorescein-isothiocyanate (FITC) used at 5 mg/ml 
dissolved in DMSO and were rotated overnight at 4°C in dark. 
FITC-labeled bacteria were washed three times with cold PBS 
and were co-incubated for 3  h with moDCs at 37 or 4°C at a 
moDC:bacteria ratio of 1:20. moDCs positive for FITC-labeled 
bacteria were analyzed by flow cytometry using FACSCalibur 
(BD Biosciences, Franklin Lakes, NJ, USA).
Flow cytometry
Phenotyping of resting and activated moDCs was performed by flow 
cytometry using anti-human CD1d-phycoerythrin (PE), CD103-
FITC, HLA-DQ-FITC, PD-L1-PE (BD Biosciences, Franklin 
Lakes, NJ, USA), CD1a-allophycocyanin (APC), CD40-FITC 
(BioLegend, San Diego, CA, USA), CX3CR1-PE, CD80-FITC, 
CD83-FITC, CD86-PE, DC-SIGN-FITC, CCR7-PE, CD14-PE 
(R&D Systems, Minneapolis, MN, USA), B7RP1 (ICOSL)-PE 
(EBiosciences, Santa Clara, CA, USA), and isotype-matched control 
antibodies. The ratio of regulatory T-lymphocytes was measured 
by flow cytometry using anti-human CD25-PE (BD Pharmingen), 
CD4-FITC (BioLegend), FoxP3-APC (R&D Systems), and anti-IL-
10-AlexaFluor488 (BioLegend). The viability of moDCs was deter-
mined with 2 µg/ml 7-amino-actinomycin D (LKT Laboratories 
Inc., St. Paul, MN, USA) dye followed by a 24-h activation period 
with live bacteria or LPS. Fluorescence intensities were measured 
by FACSCalibur (BD Biosciences), and data were analyzed by the 
FlowJo software (Tree Star, Ashland, OR, USA).
rna isolation, cDna synthesis, and  
real-time Quantitative Pcr
Briefly, total RNA was isolated by TriReagent (Molecular Research 
Centre, Inc., Cincinnati, OH, USA). Total RNA (1 µg) was reverse-
transcribed using High-Capacity cDNA Reverse Transcription 
Kit (Thermo Fischer Scientific). Gene-specific TaqMan assays 
(Thermo Fischer Scientific) were used to perform qPCR in a final 
volume of 12.5 µl in triplicates using DreamTaq DNA polymerase 
and ABI StepOnePlus real-time PCR instrument. Amplification 
of h36B4 was used as normalizing controls using specific primers 
and probe (Integrated DNA Technologies, Coralville, IA, USA). 
Cycle threshold values were determined using the StepOne 
Software, version 2.1 (Thermo Fischer Scientific). The sequences 
of the primers and probes are available upon request.
Measurement of cytokine 
concentration
Culture supernatants of moDCs were harvested 24 h after moDC 
activation, and the concentration of TNF-α, IL-1β, IL-6, IL-10, 
IL-12(p70), IL-23(p19) cytokines, and chemokine CXCL8 was 
measured using OptEIA kits (BD Biosciences) following the 
manufacturer’s instructions.
stimulation of moDcs to Measure 
T-lymphocyte Polarization
To analyze the polarized effector T cells, immature and activated 
moDCs were washed and co-cultured with peripheral blood lym-
phocytes (PBLs) for 4 days in AIM-V medium at a moDC:T-cell 
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ratio of 1:20. The T cells were analyzed for IFNγ and IL-17 secretion 
by the avidin-horseradish peroxidase (HRP)-based enzyme-
linked ImmunoSpot system (NatuTec GmbH, Frankfurt am Main, 
Germany). The co-cultures containing resting moDCs and T-cells 
as well as T-cells alone served as negative controls. To detect IL-17 
secretion, the plates were coated with 0.5 µg/ml mouse anti-hCD3 
antibody (BD Biosciences). The plates were analyzed by using 
the ImmunoScan plate reader (Cell Technology Limited, Shaker 
Heights, OH, USA). To detect regulatory T-lymphocytes, activated 
and resting moDCs were washed and co-cultured with PBL or naïve 
CD4+ T-lymphocytes for 6 days in serum-free AIM-V medium 
at a moDC:T-cell ratio of 1:10. On day 6, cells were harvested, 
permeabilized, and fixed with Citofix/Cytoperm intracellular 
staining kit (BD Biosciences). The ratio of CD4+CD25+FoxP3+ 
T cells was measured by flow cytometry. To detect the presence of 
intracellular IL-10, T cells were treated on day 6 with Golgi-Stop™ 
containing monensin (BD Biosciences) for 6  h followed by the 
surface CD25, CD4, and intracellular FoxP3 and IL-10 staining of 
cells. Naïve CD4+ T-lymphocytes were isolated by the Naïve CD4+ 
T Cell Isolation Kit II, human (Miltenyi Biotec).
stimulation of moDcs to Measure  
inKT cell expansion
Two-day moDCs were co-incubated with live bacteria, LPS, 
or 100  ng/ml α-galactosylceramide (α-GalCer, KRN7000, 
Funakoshi, Tokyo, Japan) for 24 h in AIM-V medium. Activated 
and resting moDCs were washed and co-cultured with PBL for 
5 days in AIM-V medium at a moDC:T cell ratio of 1:10 in 24-well 
plates in AIM-V medium. On day 5, cells were labeled with anti-
human CD3-PECy5, T  cell receptor (TCR) Vα24-FITC, TCR 
Vβ11-PE monoclonal antibodies (Beckman Coulter, Brea, CA, 
USA), and the double-positive iNKT population was monitored 
by flow cytometry using FACSCalibur.
Western Blotting
Cells were lysed in Laemmli buffer, and the protein extracts were 
tested by antibody specific for IRF4 diluted to 1:1,000; second-
ary antibodies were used at 1:10,000. Anti-rabbit antibody, 
conjugated to HRP (GE Healthcare Life Sciences, Little Chalfont 
Buckinghamshire, UK), was used as a secondary antibody. The 
SuperSignal ECL system was used for probing target proteins 
(Thermo Fischer Scientific). After the membranes had been 
probed for the target protein, they were stripped and re-probed 
for β-actin.
statistical analysis
Student’s unpaired two-tailed t-test or ANOVA followed by 
Bonferroni’s multiple comparison tests were used as indicated 
in the relevant experiments. In case of significantly different 
variances (P < 0.05) between the two sets of samples, the Welch’s 
correction was applied in the t-test. The results were expressed as 
mean + SD. All analyses were performed by using the GraphPad 
Prism software, version 6.0 (GraphPad Software Inc., La Jolla, CA, 
USA). Differences were considered to be statistically significant 
at P < 0.05. Significance was indicated as *P < 0.05; **P < 0.01; 
***P < 0.005; and ****P < 0.0001.
resUlTs
The expression Profile of Master 
Transcription Factors and the cell surface 
expression of cD1 glycoprotein 
receptors Differ in human moDcs
We found that in the presence of 1  nM ATRA, monocytes 
generated in the presence of GM-CSF and IL-4 induced the dif-
ferentiation of monocytes to moDCs within 2 days accompanied 
by the increasing expression levels of genes encoding the nuclear 
hormone receptor RXRα as well as its dimerization partners 
RARα and PPARγ in line with the aldehyde dehydrogenase-1 
family member A2 (ALDH1A2)/retinaldehyde-dehydrogenase 
2 (RALDH2) gene (Figure 1A) playing role in the regulation of 
retinoic acid production in moDCs. In the absence of ATRA, the 
CD1d gene was expressed in moDCs at low levels, but the CD1d 
gene transcripts and the cell surface expression of the translated 
protein was upregulated, while in ATRA-conditioned moDCs, 
the cell surface expression of CD1a decreased (Figure  1B). 
Moreover, on days 2 and 3, the differentiation of moDCs could 
be re-programmed to induce CD1d but inhibited CD1a expres-
sion, respectively (data not shown). Importantly, the cell surface 
expression of the DC-specific intercellular adhesion molecule-
3-grabbing non-integrin (DC-SIGN) remained constant at these 
conditions (Figure 1C), while ATRA maintained the expression 
level of CD14 (Figure 1D) suggesting a decelerated differentia-
tion phase of moDCs.
Dendritic cells can also be classified according to the expres-
sion levels of the transcription factors guiding both DC differen-
tiation and re-programming (39, 40). Murine models suggested 
that CD11b+ bone marrow-derived DCs cultured in the presence 
of GM-CSF and IL-4 express IRF4 and regulate the cell surface 
expression of the major histocompatibility gene complex II 
(MHC class II), while IRF4 increases the antigen-presenting 
capacity of moDCs resulting in potent T helper cell priming 
(41). In this human in  vitro model system, we also found that 
moDCs express CD11b independent on the presence of ATRA 
(Figure 1E). Interestingly, ATRA was able to downmodulate the 
gene expression levels of IRF4 (Figure 1F) while upregulated the 
cell surface expression of CD103 (Figures  3D,E). Importantly, 
the relative mRNA level of interferon regulatory factor (IRF)8, 
responsible for regulating CD103 protein expression in DCs (41), 
remained unaffected by ATRA (Figure  1G). Collectively, these 
results demonstrate that nanomolar concentration of ATRA has 
the potential to modify the moDC differentiation program in a 
coordinated manner leading to increased mRNA levels of PPARγ, 
retinoid receptors, ALDH1A2, and CD1d, while the expression 
of CD1a and IRF4 remained inhibited. Based on this finding, 
we were able to identify two separate moDC subsets exhibiting 
distinct phenotypic characteristics based on the expression pat-
terns of CD1 and CD103 proteins and transcription factors. The 
ATRA-primed CD1a−CD103+CD1d+ cells are the RARαhiIRF4lo 
subpopulation, and in contrast to this combination, the CD1a+/−
CD103−CD1d− cells are identified as a resting RARαloIRF4hi cell 
population.
FigUre 1 | The effects of all-trans retinoic acid (aTra) on human monocyte-derived dentritic cell (moDc) differentiation. Two-day moDCs were 
differentiated in the absence or presence of 1 nM ATRA. The relative gene expression levels of retinoic acid receptor alpha (RARα), retinoic X receptor alpha (RXRα), 
peroxisome proliferator-activated receptor gamma (PPARγ), ALDH1A2, and CD1d (a), interferon regulatory factor (IRF)4 (F), and IRF8 (g) were measured by 
quantitative real-time PCR, and the cell surface expression level of CD1a, CD1d (B), DC-SIGN (c), CD14 (D), and CD11b (e) was measured by flow cytometry. 
Mean values of relative mRNA levels and the ratio of moDCs positive for the measured cell surface proteins were calculated from five independent experiments +SD. 
Student’s unpaired two-tailed t-test was used in the statistical analysis with significance defined as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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stimulation of rarαloirF4hi moDcs by 
non-Pathogenic commensal Bacteria 
Polarize effector T-lymphocytes 
Differently as compared to rarαhiirF4lo 
cells
Besides the novel finding showing that the outcome of the 
inflammatory response of DCs to engulfed commensal bacteria 
is determined by the unique characteristics of the tested microbes 
(42), we were able to follow-up the immunomodulatory prop-
erties of a given microbe though monitoring the activation 
state and the direction of cell polarization of moDC-mediated 
autologous T-lymphocytes. In this experimental setting, moDCs 
were activated by live E. coli Schaedler or M. morganii both of 
them being capable to increase the number of IFNγ-producing 
T-lymphocytes (Figure 2A). By contrast, the Th17 response could 
be activated by all of the tested species (Figure 2B). In addition, 
ATRA-conditioned moDCs exhibited a completely different 
T-lymphocyte stimulatory potential as compared to moDCs 
manipulated in the absence of ATRA. In this case, the number of 
IFNγ-secreting T cells was decreased, while that of the Th17 cells 
remained undetectable in the moDC–T cell co-cultures. Taken 
the individual features of commensal bacteria, the RARαloIRF4hi 
moDCs could be activated by both E. coli Schaedler and M. 
morganii leading to the differentiation of CD4+CD25+FoxP3+ 
regulatory T-lymphocytes, while the RARαhiIRF4lo reduced this 
effect (Figures S1A,B in Supplementary Material). To confirm 
this unexpected observation, we validated the existence of the 
regulatory T-cell population by detecting the level of the IL-10 
cytokine derived from CD4+CD25+FoxP3+ T-lymphocytes co-
cultured with moDCs upon the prior activation by commensal 
bacteria (Figure S1C in Supplementary Material). Based on these 
results, we were able to identify two moDC populations, which 
respond to gut commensal species differently, but in a strain- and 
ATRA-dependent manner. To get further insight how microbiota 
species guide immune responses of distinct characteristics, we 
sought to analyze the impact of selected bacterial strains driving 
the differentiation and functional activities of moDCs by using 
various experimental approaches.
The commensal E. coli Schaedler  
and the Probiotic B. subtilis Modulate  
the cell surface expression of cD1, 
cX3cr1, and cD103 Proteins in an  
aTra-Dependent Manner
To test how gut microbiota strains may act on human moDC 
differentiation at in vitro culture conditions mimicking the intes-
tinal milieu, the cells were exposed to stimulatory signals such as 
LPS and selected live commensal bacteria. At this experimental 
FigUre 2 | Monitoring monocyte-derived dentritic cell (moDc)-
mediated T-lymphocyte polarization induced by commensal stimuli. 
The T cell polarizing capacity of moDCs was monitored in moDC stimulated 
with Escherichia coli Schaedler, Morganella Morganii, and Bacillus subtilis 
or lipopolysaccharide (LPS) followed by co-culturing the cells with freshly 
isolated autologous T cells for 4 days. The number of cytokine producing 
T-lymphocytes induced by LPS or by moDCs exposed to commensal 
bacteria was measured by interferon gamma (IFNγ) (a) and interleukin 
(IL)-17 (B) enzyme-linked ImmunoSpot assays. T corresponds to T cells 
cultured without dendritic cells as negative control. The mean value of spot 
numbers was calculated from five independent experiments +SD. ANOVA 
followed by Bonferroni’s multiple comparison tests was used in the 
statistical analysis with significance defined as *P < 0.05, **P < 0.01, and 
***P < 0.001.
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setting, exclusively E. coli Schaedler was capable to reduce the 
ratio of CD1a+ moDCs indicating the potential of this commensal 
bacterium to reduce CD1a expression selectively, but it had no 
effect on CD1d expression (Figure 3A), even though the viability 
of moDCs remained intact as compared to the immature cells 
(Figure S2 in Supplementary Material). Interestingly, B. subtilis 
exerted an opposing effect on the cell surface expression pattern 
of CD1 proteins, and LPS reduced the levels of both CD1d and 
CD1a in moDCs, while M. morganii had no effect on the cell 
surface expression level of CD1 proteins. These results indicated 
that lipid antigen presentation by moDCs via CD1a and CD1d 
proteins is regulated by both ATRA and the gut microbiota in a 
species-specific manner.
Using the in vitro system, we established the live commensal 
bacteria were able to upregulate the cell surface expression of 
CX3CR1 within 24 h (Figures 3B,C) but had no effect on CD103 
expression in the absence of ATRA (Figures  3D,E). Moreover, 
ATRA-conditioned moDCs downregulated the cell surface 
expression of CD103, but stimulation by commensal bacteria 
upregulated the CX3CR1 receptor. These data altogether con-
firmed that in the presence of live commensal bacteria, ATRA 
drives the differentiation of moDCs leading to either synergistic 
or inhibitory directions, thus modulating the cell surface expres-
sion pattern of CD1 and that of the gut-tropic proteins.
The Phagocytic capacity of moDcs 
Depends on the individual characteristics 
of the Tested Bacteria and on actual 
environmental cues
The very first steps of moDC activation and the induction of 
antigen-induced immune responses are assisted by the phago-
cytic potential and the standby physiological activities of moDCs 
(42). These events can be further modulated by the unique 
characteristics of the internalized corpuscular antigens as well as 
by the cell surface receptor repertoire of the given cell. To assess 
the phagocytic potential of the previously identified moDC 
populations, we established an in  vitro phagocytosis assay in 
which the FITC-labeled heat-inactivated bacteria were exposed 
to 37°C for 3 h, or were kept at 4°C as control (Figures 3F,G). 
As expected, the engulfment of commensal bacteria could 
be enhanced significantly and was found to be mediated 
by the RARαhiIRF4lo moDC population. When the moDCs 
were co-incubated with FITC-labeled bacteria at 4°C, back-
ground fluorescence intensities varied remarkably indicating 
differences in the individual functional characteristics of 
the tested commensal bacteria upon penetrating through 
the moDC membrane. These results altogether confirmed that 
in the  presence of gut-derived microbial stimuli ATRA supports 
the  differentiation of phagocytic CD1a−CD1d+ moDCs, while 
the expression of the gut-tropic protein CD103 is partially down-
modulated. It was also observed that in the absence of ATRA, the 
gated CD1a− and CD1a+ moDC fractions engulfed the tested 
bacteria with similar activities as the CD1a+ cells (data not 
shown). Consequently, the median fluorescence intensity values 
within the gated moDC populations of the FITC-labeled bacteria 
remained similar demonstrating that the efficacy of moDC-
mediated phagocytosis depends on both the unique features and 
the species of the engulfed bacteria, and this effector mechanism 
can be further enhanced by ATRA.
activation of rarαhiirF4lo moDcs  
by commensal Bacteria Provokes 
exacerbated inflammation as  
compared to rarαloirF4hi moDcs
Next, we continued to monitor the inflammatory potential of the 
selected commensals. Exposure of moDCs to live commensal 
bacteria such as E. coli Schaedler and B. subtilis or LPS for 24 h was 
found to increase the cell surface expression of CD83, while ATRA 
could downmodulate this response significantly (Figure 4A). The 
cell surface expression of the chemokine receptor CCR7, playing 
an essential role in driving DC migration to reach the secondary 
FigUre 3 | continued
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FigUre 3 | continued  
all-trans retinoic acid (aTra) shifts the cell surface expression pattern of cD1, gut-related receptors, and the phagocytic capacity of monocyte-
derived dentritic cells (moDcs) in an aTra and commensal strain-dependent manner. Human moDCs were differentiated in the presence of granulocyte-
macrophage colony-stimulating factor and interleukin-4 with or without 1 nM ATRA for 2 days. The surface expression level of CD1a and CD1d was measured on 
resting cells and moDCs activated with live commensal bacteria for 24 h (a) by flow cytometry. Histogram overlays show results derived from 1 representative donor 
of 10. The cell surface expression level of the mucosa-related CX3CR1 (B,c) and CD103 (D,e) was measured by flow cytometry followed by a 24-h activation period 
with live commensal bacteria or lipopolysaccharide (LPS) served as a positive control. Mean values showing the ratio of moDCs positive for the measured surface 
protein were calculated from five independent experiments +SD. To monitor the phagocytic capacity of moDCs, on day 2, moDCs were co-cultured with heat-
inactivated and fluorescein-isothiocyanate (FITC)-labeled bacteria at 37°C or at 4°C for 3 h at a moDC:bacteria ratio of 1:20. (F,g) Dot plots show one of four 
independent experiments. The ratio of moDC positive for heat-inactivated and FITC-labeled bacteria was measured by flow cytometry. The number of moDCs 
carrying FITC-labeled bacteria was calculated from four independent experiments +SD. ANOVA followed by Bonferroni’s multiple comparison tests was used in the 
statistical analysis with significance defined as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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lymphoid organs, could also be induced in the presence of LPS 
or E. coli Schaedler, but the expression level of CCR7 remained 
inhibited in ATRA-treated moDC (Figure 4B). In line with these 
results showing the potential of microbial components to gener-
ate mature moDCs, we detected the species-specific production 
of inflammatory cytokines including TNF-α, IL-1β, IL-6, and 
CXCL8 chemokine (Figure  4C). Furthermore, B. subtilis was 
found to induce negligible pro-inflammatory cytokine produc-
tion as compared to Gram-negative E. coli Schaedler, but the 
effects of B. subtilis could be boosted significantly upon ATRA 
treatment confirmed by the increased secretion of TNF-α, IL-1β, 
and IL-6. We also observed that M. morganii induced the expres-
sion of a similar panel of moDC-derived inflammatory cytokines 
as compared to that of E. coli Schaedler (data not shown).
These results collectively indicate that E. coli Schaedler and 
B. subtilis harbor individual moDC-provoking potential, while 
ATRA can boost the production of pro-inflammatory mediators. 
In contrast to this finding, the expression level of CCR7 becomes 
downmodulated presumably associated with its decreased 
migratory potential guided by the RARαhiIRF4lo moDC popula-
tion. Based on these results, we conclude that E. coli Schaedler 
acts as a potent inducer of inflammatory responses in moDCs 
accompanied by the production of TNF-α, IL-1β, and IL-6, while 
B. subtilis is less efficient to trigger TNF-α and/or IL-1β secretion.
E. coli Schaedler and B. subtilis increase 
the T-lymphocyte stimulatory and 
Polarizing capacity of moDcs but aTra 
interferes with This effect
The first signal for Th cell activation derives from the interac-
tion of the TCR with MHC class II–peptide complexes pre-
sented by antigen-presenting proteins such as HLA-DQ and 
HLA-DR inducible by LPS or by the selected microbiota strains 
(Figure 5A). When moDCs were exposed to LPS or to commen-
sal bacteria, the cell surface expression of the CD80 and CD86 
co-stimulatory molecules was increased (Figure 5B). In such an 
experimental system, the secretion of the regulatory cytokine 
IL-10 was independent on ATRA in case of moDC activation 
by bacteria. More importantly, the secretion level of the Th1 
polarizing cytokine IL-12 was decreased, while that of the IL-23 
cytokine was enhanced significantly in the RARαhiIRF4lo moDC 
population (Figure  5C). Interestingly, B. subtilis was unable to 
induce IL-23 secretion and the level of IL-12 also remained lower 
than the effect provoked by moDCs in the presence of the Gram-
negative commensal bacterium E. coli Schaedler.
Considering that the differentiation of T-lymphocytes is 
regulated by both co-stimulatory and inhibitory signals, the cell 
surface expression of known co-stimulators of T-lymphocytes 
were also monitored. The results revealed that the cell surface 
expression of the co-stimulatory molecule CD40 could be 
induced by LPS and also by the two commensal strains, and this 
effect could be slightly enhanced in PPARγhiIRF4low moDCs upon 
activation by E. coli Schaedler (Figure 5D). The induction of the 
effector T cell inhibitor PD-L1 could also be achieved if moDCs 
were stimulated by E. coli Schaedler (Figure 5E), in contrast to 
B. subtilis or LPS with no such effects. These data altogether suggest 
that both LPS and gut-associated commensal bacteria can induce 
the cell surface expression of T cell co-stimulatory and inhibitory 
molecules on the moDC cell surface in a strain-dependent man-
ner, while ATRA-activated moDCs exhibit impaired cell surface 
expression of MHC class II, co-stimulatory, and inhibitory cell 
surface proteins.
limited commensal-induced effector 
responses Mediated by rarαhiirF4lo 
moDcs are associated with augmented 
inflammation That can Be rescued by the 
selective inhibition of rarα
In a next step, we addressed the question how T-lymphocyte 
stimulation and maturation may modulate moDC responses in 
the presence of ATRA or commensal bacteria. Taken the fact 
that differentiation of moDCs can be modified in the presence 
of 1 nM ATRA, we also confirmed that the blockade of RARα 
signaling by a specific antagonist resulted in the prevention of 
CD1d and CD103 expression, while in the presence of ATRA, the 
cell surface expression of CD1a remained similar as control cells 
(Figure 6A). The chemical antagonist of RARα, i.e., BMS614 was 
unable to increase the cell surface expression level of CD1a on the 
cell surface showing that a minimal concentration of endogenous 
ATRA is presented by moDCs.
In a further step, we also demonstrated that the enhanced 
secretion of the pro-inflammatory cytokines (Figure  6B) and 
IL-23 (Figure 6C) induced by commensal bacteria could be ame-
liorated by the prior blockade of RARα. Moreover, the reduced 
antigen-presenting capacity of the ATRA-conditioned moDCs 
could be restored by the inhibition of RARα (Figure 6D).
FigUre 4 | characteristics of the inflammatory and migratory potential of monocyte-derived dentritic cell (moDc) populations induced by 
commensal bacteria. Two-day moDCs were co-incubated with live commensal strains or with 250 ng/ml lipopolysaccharide (LPS) used as control for 24 h. 
Expression of the moDC-associated activation marker CD83 (a) and CCR7 (B) was measured by flow cytometry. Mean values were calculated from five to seven 
independent experiments +SD. The concentration of TNF-α, interleukin (IL)-1β, IL-6 pro-inflammatory cytokines, and the chemokine CXCL8 (c) was measured by 
ELISA followed by a 24-h activation of moDC in five independent experiments. Mean values +SD are shown. ANOVA followed by Bonferroni’s multiple comparison 
tests was used in the statistical analysis with significance defined as *P < 0.05, ***P < 0.001, and ****P < 0.0001.
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Considering that the IRF4 transcription factor plays a pivotal 
role in setting the degree of DC-mediated antigen presentation 
(41), in a final experimental setting, we described for the first 
time in human moDCs that the protein level of IRF4 could be 
upregulated by live commensal bacteria and this effect could 
be decreased in a RARα-dependent manner (Figure  6E). 
As we expected, the decreased effector T-lymphocyte polar-
izing capacity of moDCs could be recovered by the selective 
blockade of RARα leading to strong Th1 (Figure 6F) and Th17 
(Figure  6G) responses against the selected microbiota strains. 
FigUre 5 | continued
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FigUre 5 | continued  
The T-lymphocyte activating and polarizing capacity of monocyte-derived dentritic cells (moDcs) activated by selected commensal bacteria. 
Two-day moDCs were co-incubated with live commensal strains or with 250 ng/ml lipopolysaccharide (LPS) used as control for 24 h. The expression levels of 
HLA-DQ and HLA-DR (a), the co-stimulatory proteins CD80 and CD86 (B), CD40 (D), and the inhibitory molecule PD-L1 (e) was measured by flow cytometry. 
Mean values of median fluorescence intensities (MFIs) were calculated from five to seven independent experiments +SD. The concentration of interleukin (IL)-12, 
IL-23, and IL-10 cytokines was measured by ELISA followed by a 24-h activation of moDC and was tested in seven independent experiments (c). Mean values 
+SD are shown. ANOVA followed by Bonferroni’s multiple comparison tests was used in the statistical analysis with significance defined as *P < 0.05, **P < 0.01, 
***P < 0.001, and ****P < 0.0001.
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Based on these results, we propose that the differentiation 
program of moDC initiated by GM-CSF and IL-4 can readily 
be modulated by ATRA, and this effect is associated specifically 
to the RARα nuclear receptor. In line with the results showing 
that ATRA is able to downmodulate the gene expression of IRF4 
in both resting and ATRA-conditioned activated moDCs in the 
presence of commensal bacteria, the cell surface expression of 
antigen-presenting HLA-DQ molecules is decreased in a RARα-
dependent manner.
DiscUssiOn
This study focuses to the interplay of moDCs differentiated in vitro 
and designed to accommodate to various microenvironments 
having the potential to guide autologous effector T-lymphocyte 
functional activities. In this context, the polarization and the 
actual expression patterns of the cell surface molecules exhibiting 
co-stimulatory and/or inhibitory potential were monitored in the 
presence and absence of selected members of the gut microbiota 
exemplified by E. coli Schaedler, M. morganii, and B. subtilis. 
Based on our concept, the outcome of moDC differentiation 
is able to accommodate to unique cellular microenvironments 
(21, 44) and remains remarkably plastic until the terminal 
differentiation of the moDCs ensues. In line with this, we also 
demonstrated that during the very early phase of moDC differen-
tiation, the cells remain programmable at physiologically relevant 
doses of environmental cues such as in the presence of nanomolar 
ATRA (45). Importantly, these events can be prevented by the 
selective ligation of RARα acting through its natural antagonist 
resulting in a moDC phenotype similar to that of the “gold stand-
ard” of moDCs (43) differentiated by GM-CSF and IL-4.
In a retinoid-rich milieu, moDCs shift the cell surface 
expression pattern of CD1 proteins, and in resting moDCs, 
the expression level of CD103 remains inducible supporting 
the development of a mucosa-related phenotype (46, 47). This 
observation allowed us to distinguish the characteristics of the 
expressed cell surface molecules such as CD1 and CD103 on 
various moDC types. These proteins can be expressed by the 
CD1a+/−CD1d−CD103− and the CD1a−CD1d+CD103+ cell popu-
lations, respectively (Figure 7A).
We first characterized and compared the expression levels of 
the contributing transcription factors, including IRF4, PPARγ, 
and RARα in moDCs. DCs expressing IRF4 were shown to be 
the less potent inducers of cytotoxic T-lymphocytes as compared 
to cells expressing IRF8, a DC subset localized to the gut mucosa 
(39, 48). The results revealed that IRF4hi moDCs can be character-
ized as immunogenic cells provoking commensal-induced Th1 
and Th17 immune responses, but this pattern could be reduced 
in case the T  cells were primed with microbiota-stimulated 
RARαhiPPARγhiIRF4lo moDCs supporting the notion that these 
cells remain highly inflammatory, lose their potential to activate 
autologous effector T helper cells, and also lack molecular 
interactions, which may play role in preventing effector T cell 
responses induced by commensal bacteria (Figure  7B). This 
observation is further supported by previous studies showing 
that the increased expression level and activity of PPARγ is 
associated with CD1d expression and the development of tolero-
genic moDCs (20). Ligation of the CD40 cell surface molecule 
enhances the inflammatory potential of DCs (49) and the resting 
moDCs concomitantly conditioned with ATRA upregulate the 
cell surface expression of CD40, which can be further increased 
by E. coli Schaedler as compared to moDCs differentiated in the 
absence of ATRA. This observation is also confirmed by 
the concept that resting DCs express high levels of CD40 on the 
cell surface representing a semi-activated DC population with 
tolerogenic features (50, 51).
It has also been demonstrated that in the presence of heat-
killed E. coli Schaedler and B. subtilis bacteria, the phagocytic 
capacity of moDCs could be facilitated by ATRA, similar to a 
previous work showing increased PPARγ activity in moDCs 
upon internalizing corpuscular antigens more efficiently than 
moDCs with low PPARγ activity (52). In addition to these find-
ings, we also demonstrated that the stimulation of moDC with 
selected commensal bacteria resulted in moDCs expressing 
CX3CR1 supported by ATRA and showing a phenotype similar 
to that of the CD11b+CX3CR1+CD103− mononuclear mucosal 
phagocytes of myeloid origin. Moreover, in the presence of 
selected bacterial strains, the ATRA-primed moDCs induced 
the secretion of pro-inflammatory cytokines including TNF-α, 
IL-1β, IL-6, and IL-23 at high levels. Considering that these 
inflammatory cytokines play central role in the maintenance 
and/or disruption of mucosal integrity, exemplified by secreted 
IL-23 of both DC and macrophage origin. These regulatory 
circuits may serve as double-edged swords in the maintenance 
of balance in health and disease. The increased level of secreted 
IL-23 could directly be associated with several chronic inflam-
matory diseases including IBD (53). However, the presence 
of microbiota provide signals for both CX3CR1+ inflamma-
tory cells and CD11b+CD103+ DCs in the lamina propria to 
produce IL-23 and induce IL-22 secretion by innate lymphoid 
cells, thus playing a critical role in promoting mucosal healing 
in colitis (37, 54). Pro-inflammatory lamina propria-derived 
TNF-α can also exacerbate colitis through CX3CR1+ DCs indi-
cating that this DC subset also plays role in the maintenance 
of balanced inflammatory and/or standby conditions upon gut 
homeostasis (32).
FigUre 6 | continued
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FigUre 6 | continued  
The selective inhibition of retinoic acid receptor alpha (rarα) prevents the all-trans retinoic acid (aTra)-induced signature of microbiota-generated 
immune responses mediated by monocyte-derived dentritic cells (moDcs). To analyze how ATRA acts on the moDC-mediated immune response against 
microbiota species, the cells were treated with the RARα antagonist BMS614 prior to treating the cell culture medium with ATRA. The cell surface expression level of 
CD1a, CD1d, and CD103 was measured by flow cytometry in 2-day moDCs (a). The concentration of TNF-α, interleukin (IL)-6, and IL-1β (B) and IL-23 (c) was 
measured by ELISA followed by a 24-h activation of moDC performed in seven independent experiments. Mean values +SD are shown. The cell surface expression 
level of HLA-DQ was measured by flow cytometry followed by a 24-h incubation period with live commensal bacteria. (D) Mean values of cells positive for the 
measured cell surface molecules were calculated from the results of seven independent donors +SD. Analysis of interferon regulatory factor 4 (IRF4) expression in 
moDCs. (e) Two-day moDCs were activated by live commensal bacteria for 24 h, and the relative expression levels of IRF4 protein was measured by Western 
blotting. Bar graphs show IRF4/β-actin ratios measured after 24 h of stimulation. Mean values of protein densities were calculated from five independent 
experiments +SD. The T cell polarizing capacity of moDCs was monitored in moDCs activated with the selected commensal strains or with lipopolysaccharide (LPS) 
followed by co-culturing the cells with autologous T cells. Freshly isolated peripheral blood lymphocytes were co-cultured with autologous moDCs for 4 days. The 
number of cytokine producing T-lymphocytes, induced by LPS or moDCs exposed to Escherichia coli Schaedler and Bacillus Subtilis, was measured by interferon 
gamma (IFNγ) (F) and IL-17 (g) enzyme-linked ImmunoSpot assays. The mean value of spot numbers was calculated from five independent experiments +SD. 
Statistical analysis was performed by the Student’s unpaired two-tailed t-test with significance defined as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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In the presence of live bacteria, ATRA boosts the secretion 
of Th17 polarizing cytokines; however, the polarizing capacity 
of these moDCs is reduced. This observation is also supported 
by our previous study showing that moDCs “educated” by the 
supernatant of ATRA-primed colonic epithelial cells were 
able to reduce CCR7-dependent cell migration as well as their 
Th17 polarizing capacity as compared to control moDCs (44). 
Interestingly, in a murine model, Th17 differentiation was found 
to be dependent on IRF4 and IL-6 secreted by CD11b+CD103+ 
DCs derived from the mesenteric lymph nodes (55). The same 
group also showed that the human equivalent of these DCs 
could be identified as the intestinal IRF4 protein expressing 
CD103+SIRPαhi DCs.
Based on the known regulatory functions of DCs, this study 
demonstrates that the selected commensal bacteria also secrete 
IL-10, an inhibitory cytokine acting independently on the bac-
terial species. At our experimental conditions, the cell surface 
expression of PD-L1 protein became upregulated in a bacterial 
strain-dependent manner, which could be demonstrated also in 
the ATRA-primed moDCs, even though its expression level was 
significantly lower as compared to the respective ATRA free 
moDC counterpart. In addition to these results, the secretion 
of IL-12 cytokine with known inflammatory properties was 
downmodulated by ATRA as shown before by others (56). In 
contrast to these findings, we demonstrated that ATRA had no 
effect on IL-10 secretion in moDCs. Collectively, these data 
indicate that the decreased levels of IL-12, the reduced co-
stimulatory and antigen-presenting capacity of RARαhiIRF4lo 
moDCs, together with the production inhibitory IL-10 create 
a local milieu, which is inefficient to induce potent effector T 
helper cell responses upon targeting the selected gut microbiota 
species.
Our results clearly demonstrated that in resting moDCs, 
ATRA is able to upregulate the relative mRNA levels of RARα, 
previously confirmed also by others (56). In addition, we can 
exclude the effects of other RAR isoforms such as RARβ, as 
it is not expressed and the expression of RARβ could not be 
induced in moDCs in the presence of ATRA. It has also been 
shown that the effects of ATRA on the differentiation and the 
microbiota-induced stimulation of moDCs could be prevented 
by the selective inhibition of RARα, a transcription factor play-
ing critical role in regulating moDC differentiation and guiding 
mucosal immune responses. It has also been found that the 
gut microbiota has an impact on retinoid signaling-mediated 
immune homeostasis transmitted by microbial metabolites 
such as short-chain fatty acids (57). Furthermore, retinoid sup-
plementation through diet also acts on the composition of the 
gut microbiota and on energy metabolism of the host (58). For 
example, vitamin A deficiency causes perturbations in the gut 
microbiota by reducing the ratio of Firmicutes and Proteobacteria 
on a Myd88- and TRIF-dependent manner (59). It has previously 
been demonstrated that RA is associated to inflammatory mac-
rophages, as patients with Crohn’s disease exhibit an increased 
capacity to generate RALDH-derived RA, which is associated 
with CD14+ macrophages derived from the intestinal mucosa, 
thus maintaining an inflammatory phenotype mediated by 
RARα (26). This group also showed that clinical samples derived 
from Crohn’s disease patients involve both CD103+ and CD103− 
DCs with elevated expression levels of the ALDH1A2 gene, 
which is undetectable in RA-producing macrophages. Retinoids 
involving ATRA also improves the antitumor immunity in 
microbiota-induced colorectal cancer, as it increases the efficacy 
of tumor-specific cytotoxic T-lymphocytes by increasing RARα-
mediated MHCI expression in tumor cells (60).
Human moDCs not only provoke antigen-specific immune 
responses but also induce the activation and expansion of 
innate lymphoid cells; among them, iNKT cells (20, 61) and also 
present lipid antigens via cell surface CD1 glycolipid receptors. 
Remarkably, the level of CD1a and CD1d expression can be 
modified by commensal bacteria to different extents supporting 
the notion that this effect is not even related to the local lipid/
retinoid environment, the activity of PPARγ (21), or the presence 
of pathogenic microbes (62), but their activities may resemble 
some microbiota species such as E. coli Schaedler and B. subtilis. 
moDCs with increased PPARγ activity also induce the expansion 
of IFNγ-secreting iNKT cell at high levels as compared to moDCs 
with low PPARγ activity (52). Surprisingly, we were unable to 
detect changes in the number of iNKT  cells in moDCs stimu-
lated by commensal bacteria, when the activated moDC–T cell 
cultures were tested. Instead, moDCs generated processed lipid 
antigens derived from commensal bacteria indicating that these 
lipids are unable to provide ligands for CD1a or CD1d proteins 
(Figure S3 in Supplementary Material). However, it was previ-
ously reported that bacterial colonization of the murine colon 
FigUre 7 | The role of retinoic acid receptor alpha (rarα) in guiding monocyte-derived dentritic cell (moDc) development and microbiota-induced 
immune responses. All-trans retinoic acid (ATRA) modifies the differentiation of moDCs that could be prevented by the selective inhibition of RARα. (a) In the 
presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4, monocytes differentiate to CD1d−CD1a+ DCs (43). Peroxisome 
proliferator-activated receptor gamma (PPARγ) and RARα regulate the gene expression of CD1d and ALDH1A2 both directly and indirectly in human moDCs (20). 
Interferon regulatory factor 4 (IRF4) mediates the differentiation and antigen-presenting capacity of human moDCs, which is downregulated by the ligation of RARα 
resulting in decreased mRNA and protein levels of IRF4 together with CD1a. Selected microbiota species provoke different types of immune responses mediated by 
moDCs. (B) Escherichia coli Schaedler induces full maturation in moDCs leading to strong inflammatory and microbiota-induced effector helper T (Th) responses, 
while Bacillus subtilis induces inflammation in the absence of IL-12 and IL-23 and provokes decreased effector Th1/Th17 immune responses. ATRA downmodulates 
the immunogenicity of moDCs resulting in diminished Th1 and undetectable Th17 responses, which effect can be restored in moDCs by the prior inhibition of RARα 
in moDCs. Solid lines represent known mechanisms; dotted lines indicate unknown molecular interactions.
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with E. coli Schaedler stimulates intestinal epithelial cells and 
intraepithelial innate lymphoid cells (63) independently, and this 
effect may play role in the pathogenesis of colitis as demonstrated 
in adoptive transfer models using SCID mice, which may also 
operate in patients with IBD.
Collectively, we offer a sensitive in  vitro assay system 
appropriate for the comparative analysis of selected individual 
microbes in the course of collaboration with human phagocytic 
cells such as primary moDCs, playing essential roles in orches-
trating the outcome of immune responses. We also confirmed 
that the vitamin A derivative ATRA has the potential to drive the 
differentiation program of moDCs in a RARα-dependent man-
ner and thus confers suppressive signals during gut commensal 
bacteria-induced effector T-lymphocyte responses in line with 
enhancing their local inflammatory potential.
The interactions of diet, gut microbiota and the host build 
up a highly complex network of regulatory circuits to drive the 
development of both mucosal and systemic immune responses. 
Preferentially in early childhood, imbalances in food supple-
mentation together with the acquired perturbance of the gut 
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FigUre s1 | regulatory T-lymphocyte polarizing capacity of monocyte-
derived dentritic cell (moDc) populations stimulated by Escherichia coli 
Schaedler, Morganella morganii, and Bacillus subtilis. To detect the 
number of regulatory T-lymphocytes, resting and stimulated moDCs were 
co-cultured with peripheral blood lymphocyte for 6 days. The ratio of 
CD25+FoxP3+ Treg cells (a,B) and the interleukin (IL)-10-producing Treg cells  
(c) were analyzed by flow cytometry, respectively. Dot plots show one out of five 
independent experiments. The mean value of Treg cell numbers was calculated 
from five independent experiments +SD. In the statistical analysis, ANOVA 
followed by Bonferroni’s multiple comparison tests were used with significance 
defined as *P < 0.05.
FigUre s2 | Monitoring the viability of monocyte-derived dentritic cells 
(moDcs) exposed to live commensal bacteria in the absence or presence 
of all-trans retinoic acid (aTra). moDCs were differentiated with or without 
ATRA for 2 days in serum-free culture medium. On day 2, moDCs were 
co-incubated with live commensal bacteria for 24 h followed by labeling the cells 
with 7-amino-actinomycin D (7-AAD) dye. Mean values of moDCs positive for 
7-AAD staining were calculated from five independent experiments +SD.
FigUre s3 | The invariant natural killer T (inKT) cell inducing capacity of 
monocyte-derived dentritic cell (moDc) populations stimulated by 
Escherichia coli Schaedler and Bacillus subtilis. To detect the number of 
iNKT cells, moDCs were stimulated with live bacteria or with lipopolysaccharide 
(LPS) followed by co-incubation with autologous peripheral blood lymphocyte for 
5 days, and the moDC cultures were incubated with the CD1d ligand α-GalCer 
served as a positive control. The ratio of CD3+ cells expressing Vα24Vβ11 T cell 
receptors was analyzed by flow cytometry. The mean values of iNKT cell 
numbers were calculated from three independent experiments +SD.
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